ORIGINAL RESEARCH article

Front. Aging, 22 July 2025

Sec. Healthy Longevity

Volume 6 - 2025 | https://doi.org/10.3389/fragi.2025.1548667

Chronic pain in the Chilean population: risk factors prevalence and cognitive associations

  • 1. Latin American Institute for Brain Health (BrainLat), Universidad Adolfo Ibáñez, Santiago, Chile

  • 2. Department of Human Genetics, Radboud University Medical Center, Nijmegen, Netherlands

  • 3. Global Brain Health Institute, Trinity College, Dublin, Ireland

  • 4. Global Brain Health Institute, University of California San Francisco (UCSF), San Francisco, CA, United States

  • 5. Cognitive Neuroscience Center, Universidad de San Andrés and Consejo Nacional de Investigaciones Científicas y Técnicas, Buenos Aires, Argentina

  • 6. Specialist in Physical Medicine and Rehabilitation, Physical Medicine and Rehabilitation Service San Borja Arriaran Clinical Hospital, Pontificia Universidad Católica de Chile Health Network, Santiago, Chile

  • 7. Department of Psychiatry, Neuropsychology and Clinical Neuroscience Laboratory (LANNEC), Faculty of Medicine, Universidad de Chile, Santiago, Chile

  • 8. Escuela de Psicología, Facultad de Ciencias, Universidad Mayor, Las Condes, Chile

  • 9. Brain and Mind Centre, School of Psychology, The University of Sydney, Sydney, Australia

  • 10. Department of Neurology, Faculty of Medicine, Universidad Finisterrae, Santiago, Chile

  • 11. Memory Unit Neurology Service, Hospital del Salvador, Santiago, Chile

  • 12. Pontificia Universidad Javeriana (PhD Program in Neuroscience) Bogotá, San Ignacio, Colombia

  • 13. Center of Memory and Cognition Intellectus, Hospital Universitario San Ignacio Bogotá, San Ignacio, Colombia

  • 14. Instituto Peruano de Neurociencias, Unidad de diagnóstico de deterioro cognitivo y prevención de demencia, Lima, Peru

  • 15. Biomedical Science Institute, Faculty of Medicine, Universidad Católica de Cuyo, San Juan, Argentina

  • 16. Consejo Nacional de Investigaciones Científicas y Técnicas, Buenos Aires, Argentina

  • 17. L’Institut National de la Santé et de la Recherche Médicale (INSERM), Bordeaux Population Health Research Center, UMR 1219, University Bordeaux, Bordeaux, France

  • 18. Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico

  • 19. Instituto de Envejecimiento, Facultad de Medicina, Pontificia Universidad Javeriana, Bogotá, Colombia

  • 20. Mental Health Department, Hospital Universitario Santa Fe de Bogotá, Bogotá, Colombia

  • 21. Faculty of Engineering and Sciences, Universidad Adolfo Ibáñez, Santiago, Chile

  • 22. Data Observatory Foundation, Santiago, Chile

  • 23. Centro de Investigación Biomédica, Facultad de Medicina, Universidad Diego Portales, Santiago, Chile

Abstract

Chronic pain (CP) is a global public health issue and a critical factor in the aging process. Chile, as one of the most aged countries in Latin America, presents a unique context for exploring CP and its associated factors. Despite its significance in aging, previous studies in the region often fail to comprehensively address key variables such as age, income, mood, mobility, diet, and cognitive skills, nor do they systematically investigate the relationship between CP and cognitive impairment. This study presents a comprehensive analysis of CP prevalence, related sociodemographic and health variables, and its link to cognitive impairment, using representative data of the Chilean population 15 years and older from the 2009–2010 and 2016–2017 Chilean National Health Surveys (CNHS). In the expanded sample of 12,791,542 and 13,399,937 individuals respectively, the overall prevalence of CP was 46.0% in the 2009–2010 CNHS and 28.9% in the 2016–2017 CNHS, with prevalence increasing with age. CP ranged from 26.6% among individuals aged 15–24 years to 59.9% among those aged 65–80 years in the 2009–2010 CNHS, and from 16.6% to 40.2% in the 2016–2017 CNHS. Female participants consistently reported higher CP rates, with significantly higher prevalence than males across age groups 15–64 years. Using complex survey logistic regression analyses, we identified several factors that were significantly associated with CP, including reduced mobility, depression, anxiety, socioeconomic disadvantage, and lower educational attainment. Machine learning techniques were employed to classify CP and non-CP cases, providing a nuanced understanding of the complex interplay between factors that influence CP. In a secondary analysis among those 60 years and older, no significant difference in CP prevalence was observed between individuals with and without cognitive impairment measured with an abbreviated MiniMental State Examination test. However, those with cognitive impairment tended to report pain in a greater number of anatomical sites. This study provides the first nationally representative evidence of CP in Chile in relation to age, income, mood, mobility, diet, and cognitive performance. These findings contribute to the understanding of CP as a public health issue in Latin America. The study underscores the need for targeted interventions to promote healthy longevity and reduce the burden of chronic diseases in aging populations.

1 Introduction

Chronic pain (CP) is characterized by pain persisting beyond the expected healing period or lasting for more than 3 months (). Unlike acute pain, which typically arises in response to a discernible noxious stimulus, CP can manifest and persist in the absence of apparent harm (). The global burden of CP is substantial, affecting approximately 28% of the worldwide population, with prevalence increasing notably with age (). From an economic perspective, excluding institutionalized individuals, the cost of CP is estimated to range between 560 and 635 billion dollars annually due to medical expenses and productivity losses in America ().

Throughout Latin America (LA), CP prevalence varies significantly across regions (; ; ; ; ; ; ). Although studies in Chile report CP prevalence between 32.1% and 34.7% (; ), these studies often have limitations and lack representativeness. Specifically, previous studies have frequently overlooked key demographic and socioeconomic factors unique to the population and fail to fully capture CP prevalence within the aging demographic.

The high prevalence reported in LA and Chile could be attributed to identified risk factors, including age, female sex, low education level, and depressive symptoms (; ; ; ; ; ). Additionally, CP is associated with impairments in daily activities, malnutrition, sleep disorders, anxiety, depression, suicidal ideation, and suicidal behavior (; ; ; ; ; ; ; ; ; ). Pronounced social inequality also affects the perception and occurrence of CP, highlighting the significant influence of environmental factors in CP (; ; ; ). CP has also been associated with pathological aging (; ; ; ; ; ; ; ). Emerging evidence, particularly from high-income countries and based on extensive cohort studies, suggest that greater CP is associated with cognitive decline (; ; ; ). This relationship, however, has not been systematically explored in LA (; ; ; ; ; ). Furthermore, despite the biological and social diversity in Chile and the high prevalence of CP in the country (; ), the factors associated with CP that are specific to this context have not been thoroughly explored. In addition, the relationship between CP and cognitive impairment among older Chilean adults remains unexamined.

Firstly, this study aimed to assess the prevalence of CP and its association with key demographic, socioeconomic, and health-related variables; secondly, it sought to explore the potential relationship between CP and suspected cognitive impairment (hereinafter referred to as cognitive impairment) among older adults. We hypothesized that CP in Chile is associated with specific regional adverse socioeconomic (; ; ; ) and health conditions (; ; ; ). Further, we anticipated that these factors would vary based on sex and age (; ; ).

2 Materials and methods

2.1 Study design

This cross-sectional study was based on two nationally representative cycles of the Chilean National Health Survey (CNHS): 2009–2010 () and 2016–2017 (). These prevalence studies are surveys conducted by the Ministry of Health to assess the population’s health status and associated sociodemographic and clinical factors. Both surveys employed a stratified, multistage probability sampling design to ensure representativeness of the Chilean population 15 years and older. We selected these two specific survey waves because they are the most recent to include harmonized data on CP, cognitive function, mood disorders, mobility, nutritional status, and socioeconomic conditions. The protocol was approved by the Research Ethics Committee of the Pontificia Universidad Católica de Chile (No. 16–019) and authorized by the Public Health Subsecretariat. Written informed consent was obtained from all participants, in accordance with the Declaration of Helsinki. Supplementary Figure 1 displays the data processing pipeline, including dataset selection, feature extraction, outcome definitions, statistical approaches, classifier details, and performance results.

2.2 Study population

The CNHS cross-sectional studies conducted in 2009–2010 and 2016–2017 surveyed a total of n = 5,290 and n = 6,051 individuals aged 15 years and older, respectively. In the current study, we included participants with available data on self-reported CP, comprising n = 4,683 for the CNHS 2009–2010 and n = 4,887 for the CNHS 2016–2017, corresponding to an expanded population of 12,791,542 and 13,399,937 respectively (Supplementary Figure 1A). Exclusion criteria considered individuals older than 80 years (n = 190 in 2009–2010 and n = 274 in 2026–2017) to prevent outliers, those who reported cancer diagnosis (n = 30 in 2009–2010 and n = 243 in 2026–2017) to focus on non-cancer CP, and those with missing data on the analytical variables (n = 387 in 2009–2010 and n = 647 in 2026–2017). Additional analysis on the relationship between CP and cognitive impairment was conducted among a sample of n = 1,104 (2009–2010, expanded population of 2,049,500), and the n = 1,401 (2016–2017, expanded population of 2,214,309) adults 60–80 years. Overall, both surveys were selected due to their population representativeness, the inclusion of a large number of individuals living with CP and the comprehensive clinical and sociodemographic data available.

2.3 Variables

Data in the 2009–2010 and 2016–2017 CNHS were collected during home interviews by trained interviewers. The same methods were used across both surveys.

2.3.1 Outcome variables

2.3.1.1 Chronic pain

In this study the presence of CP was classified dichotomously identifying whether participants had self-reported none-cancer CP. Non-cancer CP was defined as an unceasing pain lasting more than 3 months or a pain that persists beyond the normal healing time, which usually has no protective function, impairs health, and causes substantial disability (). In addition, participants were interviewed regarding the joints where they experienced pain in the past weeks and the duration of this pain. Further, data were collected on the number of anatomical sites in which participants reported feeling pain, including the neck, shoulder, upper back, lower back, elbow, wrist, fingers, hip, knee, ankle, and toes. Single-site pain referred to pain localized to a specific area of the body, while multiple-site pain encompassed pain experienced across multiple body regions.

2.3.1.2 Cognitive function

Among those 60 years and older, an abbreviated validated Chilean version of the Mini-Mental State Examination (MMSE) instrument was used to assess suspected cognitive function. The MMSE measures cognitive domains including orientation, attention, recent memory, and language (). This version comprises six questions with a possible score ranging from 0 to 19. A score 13 or lower was considered as evidence of cognitive impairment (). For this analysis, the MMSE score and the number of painful sites were treated as binary outcomes based on established cutoffs (≤13).

2.3.2 Predictors

2.3.2.1 Demographics

Demographic features included sex (female or male, no questions regarding gender identity were made), educational attainment (years of education completed) and age.

2.3.2.2 Socioeconomic status (SES)

Data on access to electricity, potable water, sanitation facilities, cooking fuel, and household equipment was collected. Further, a SES score ranging from 0 to 10 was created, assigning one point for each positive condition and calculated a percentage based on 10, where 10 signifies the maximum score assigned to homes with optimal conditions ().

2.3.2.3 Mood disorders

Mood disorders covered in the study consisted of self-reported cases of anxiety and depression among the participants, based on data from the psychosocial module. Participants were asked about the frequency of their feelings of anxiety or stress, rated on a four point Likert scale raining from. i) never, ii) sometimes at home or work, iii) several times at home or work, or iv) permanently at home or work. Individuals who reported feeling stress on a permanent basis or several times throughout the week were classified as suffering from anxiety. Participants were also asked to rate their emotional state on a three point scale: i) I am not distressed or depressed, ii) I am moderately distressed or depressed, or iii) I am very distressed or depressed. Individuals who reported being moderately or very distressed or depressed were classified as suffering from depression.

2.3.2.4 Nutritional status

The Body Mass Index (BMI) in the survey was derived as body weight divided by height squared, measured by a trained nurse/interviewer. Subjects having a BMI lower than 18.5 classified as underweight (malnutrition), those with BMI 18.6 to 24.9 as normal weight, those with BMI 25 to 29.9 are overweight, while a BMI greater than 30 classified as obese ().

2.3.2.5 Mobility reduction

The assessment of mobility was based on participants’ reports of their limitations in proper movement. Subjects are asked if they have difficulty walking, required assistance to move around or if they have to stay at home due to their walking problems.

2.4 Statistical analyses

The characteristics of the study population were described using means and standard deviations (SD) for numerical variables with a normal distribution, and medians with interquartile ranges (IQR) for those not normally distributed. For categorical variables, absolute and relative frequencies were used. Furthermore, the prevalence of CP was calculated using an expansion factor, as indicated in the survey’s methodological analysis manual, and stratified by sex and age groups: a) 15–24 years, b) 25–44 years, c) 45–64 years, and d) 65–80 years.

To assess the association between the presence of CP (dependent variable) and lower mobility, nutritional status, and self-reported mood disorders (independent variables), we used complex survey logistic regression models, adjusting for SES, education, sex, age, and geographical region. Next, we examined the association between CP and both education and SES, using sex, age, and geographical region as covariates. Results were expressed as odds ratios (ORs) and 95% confidence intervals (95% CI) (; ), and analyses were conducted separately for each survey. An OR greater than one indicates higher odds of the event (presence of CP) occurring in the reference group; an OR less than one indicates lower odds; and an OR equal to one suggests no association.

In the secondary analysis among those 60–80 years, we used the presence of cognitive impairment (yes/no) as the dependent variable to study the association with the presence of CP and with the number of pain sites. For this, we conducted complex survey logistic regression models, adjusting for SES, education, sex, age, and geographical region within the country.

To evaluate the capacity for distinguishing between CP and non-CP cases across the whole sample, we employed the XGBoost classification algorithm (). The analyses were conducted separately for each survey and were further stratified by cognitive impairment status. XGBoost is a machine learning algorithm that has emerged as a high-performance alternative (; ). Based on extreme gradient boosting principles, it has consistently outperformed in various applications (; ). Models were trained on an 80% training sample and subsequently tested on a 20% testing set, with k = 10 repetitions (). For each iteration, the f-score for the features, Area Under the Curve (AUC), accuracy, precision, f1, and recall were computed. Mean f-scores for each feature, along with their standard deviations, were reported. Bayesian optimization was employed to identify the optimal hyperparameters for XGBoost. By delineating a search space for hyperparameters, employing a surrogate probabilistic model, and iteratively proposing new configurations, Bayesian Optimization efficiently explores the parameter space (). By introducing XGBoost models, we leveraged a powerful machine learning algorithm capable of capturing complex patterns and interactions within the data, which traditional logistic regressions might overlook. XGBoost also allows for better handling of large and unbalanced datasets, improving the overall model performance. The ability to optimize hyperparameters using Bayesian optimization further enhances the precision and accuracy of the predictions, providing a more comprehensive analysis compared to logistic regressions alone. All analyses were conducted in Python (v3.12.4) using the statsmodels, scikit-learn, and XGboost packages, and Stata (SB v18.0) (; ).

3 Results

A baseline description of the study population’s characteristics is presented in Table 1. The mean [SD] age of respondents in the 2009–2010 survey was 44.87 [17.4] years (female: 45.06 [17.2], male: 44.85 [17.6]), while in the 2016–2017 survey it was 46.88 [18.0] years (female: 47.27 [17.8], male: 46.23 [18.4]). The mean number of years of education in 2009–2010 was 9.88 [4.1] years (female: 9.79 [4.2], male: 10.03 [4.1]), and in 2016–2017 it was 10.35 [4.1] years (female: 10.17 [4.1], male: 10.64 [4.1]).

TABLE 1

CNHS surveyNumber of analyzed subjectsRepresentative sampleAverage of age (SD)Average of education years (SD)Subjects suffering CP (%)Subjects older than 60 years oldSubjects older than 60 years old with cognitive impairment
2009–20104,68312,791,54244.87 (17.4)9.88 (4.1)2,1791,10490
F: 59.3%F: 45.06 (17.2)F: 9.79 (4.2)F: 64.9%F: 56.5%F: 44.4%
M: 40.7%M: 44.85 (17.6)M: 10.03 (4.1)M: 35.1%M: 41.5%M: 55.6%
2016–20174,88713,399,93746.88 (18.0)10.35 (4.1)1,4471,401133
F: 62.2%F: 47.27 (17.8)F: 10.17 (4.1)F: 69.6%F: 62.1%F: 57.1%
M: 37.8%M: 46.23 (18.4)M: 10.64 (4.1)M: 30.4%M: 37.9%M: 42.9%

Demographic, education, and chronic pain data from the CNHS 2010 and CNHS 2016 Surveys.

In regard to cognitive status among those 60–80 years old, 90 out of/1,104 (2009–2010 survey) and 133 out of/1,401 (2016–2017) participants presented with cognitive impairment. in those aged 60 and over.

3.1 Chronic pain prevalence in Chile

In the 2009–2010 survey, 2,179 subjects reported experiencing CP (female: 64.9%), while in the 2016–2017 CNHS, 1,447 subjects reported suffering from CP (female: 69.6%).

Furthermore, CP prevalence tended to be higher in older age groups, with the highest age-specific prevalence observed among individuals aged 65–80 years. Specifically, this group showed a prevalence of 59% (95% CI: 52%–66%) in the 2009–2010 survey and 42% (95% CI: 31%–53%) in the 2016–2017 survey (Figures 1A, B, left panels; Supplementary Table 1). Notably, women reported higher CP rates than men across all age ranges in both surveys. These sex differences were statistically significant in the 15–64 age range (p < 0.05) but not in the 65–80 age group, where the differences were no longer significant.

FIGURE 1

Women reported a higher proportion of CP than men across all age groups in both the 2009–2010 and 2016–2017 surveys (Figures 1A, B, right panels; Table 2).

TABLE 2

Age range (years)SexCNHS 2009–2010CNHS 2016–2017
Proportion95% conf. intervalProportion95% conf. interval
15–24Male0.200.14–0.280.020.004–0.11
Female0.300.24–0.360.250.16–0.37
25–44Male0.370.31–0.430.160.10–0.25
Female0.470.41–0.530.350.24–0.48
45–64Male0.450.38–0.520.300.20–0.41
Female0.620.57–0.670.460.37–0.57
65–80Male0.520.41–0.630.340.20–0.52
Female0.650.57–0.720.490.36–0.62

Proportions of CP by age range and split by sex, for the 2009–2010 and 2016–2017 CNHS surveys.

Moreover, regarding the number of body pain sites, in the 2009–2010 survey, individuals aged 65–80 years were more likely to experience multi-site CP than single-site CP (Figure 1C; Supplementary Table 2). To explore whether the observed age-related patterns in CP extend beyond body site distribution, we performed a trend analysis examining the general association between age and CP. We found a significant positive relationship in both 2009–2010 (OR = 7.80 [5.98–10.18]) and 2016–2017 (OR = 5.24 [4.00–6.88]) surveys. This association remained statistically significant despite a slight decrease in magnitude over time. Additionally, age distributions differed significantly between individuals with and without CP (p < 0.0001), with moderate effect sizes in both periods (d = 0.49 and d = 0.41). These findings provide further evidence that age plays a stable and substantial role in CP prevalence across aging (Figures 1E, F).

A more detailed analysis of specific pain locations in the 2009–2010 survey reveals that knee and low back pain were the most commonly affected areas in the Chilean population (Figure 1G; Supplementary Table 3), and this pattern persisted in the 2016–2017 survey (Figure 1H; Supplementary Table 3).

3.2 Main factors associated with CP in Chile

Our analysis demonstrated that reduced mobility emerges as the most pronounced factor linked with CP across both the 2009–2010 and 2016–2017 surveys, with an OR of 2.76 [2.13–3.59] and 3.30 [1.88–5.79], respectively (Figures 2A, B). Similarly, greater anxiety was consistently associated with presence of CP in both survey periods (Figures 2A, B). Additionally, the presence of depression was significantly associated with CP in the 2009–2010 survey only (Figure 2A). Furthermore, no association was observed with nutritional status in either survey (Figures 2A, B).

FIGURE 2

Moreover, we observed that individuals with higher SES (OR: 0.91 [0.85–0.98]) and higher educational attainment (OR: 0.96 [0.93–0.98]) were less likely to report presence of CP compared to those with lower SES and educational levels in the 2009–2010 survey (Figure 2C), respectively. Contrarily, no significant associations were observed for the 2016–2017 survey (p values ≥ 0.05) (Figure 2D).

The classification analysis aimed at identifying primary factors associated with CP in the 2009–2010 and the 2016–2017 CNHS surveys emphasized age as the predominant risk factor in both survey periods (Figures 2E, F). Additionally, sex, education, and SES exhibited significant association with CP occurrence among the Chilean population (Figures 2E, F). Notably, self-reported mental mood disorders such as anxiety and depression also emerged as factors associated with CP. Malnutrition (unhealthy weight) demonstrated the lowest frequency in CP presence (Figures 2E, F). Additionally, in the CNHS 2009–2010 survey, we achieved the following classification performance for CP vs. non-CP cases AUC = 0.73 (0.015), accuracy = 0.67, precision = 0.67, f1-score = 0.68, and recall = 0.68. Moreover, for the 2016–2017 survey, the results were as follows: AUC = 0.77 (0.030), accuracy = 0.69, precision = 0.68, f1-score = 0.70, and recall = 0.72.

3.3 Chronic pain and its association with cognitive impairment

In the 2009–2010 survey, the prevalence of CP in individuals aged 60–80 years was comparable between those with normal cognitive function (58% [95% CI: 52%–64%]) and those experiencing cognitive impairment (54% [95% CI: 38%–0.70%]) (Figure 3A, left panel. Table 3). Importantly, in sex-specific analysis among individuals with cognitive impairment, female participants showed a slightly higher prevalence of CP (73% [95% CI: 53%–87%]), as compared to males (40% [95% CI: 21%–62%]) (Figure 3A, right panel; Table 3).

FIGURE 3

TABLE 3

CognitionSexCNHS 2009–2010CNHS 2016–2017
Proportion95% conf. intervalProportion95% conf. interval
No-cognitive impairmentTotal0.580.52–0.640.390.30–0.49
Male0.490.39–0.580.260.16–0.39
Female0.660.59–0.720.550.42–0.67
Cognitive impairmentTotal0.540.38–0.700.400.19–0.65
Male0.400.21–0.620.180.06–0.47
Female0.730.53–0.870.520.23–0.79

Proportions of CP among individuals aged 60 and older, segmented by sex, for the CNHS surveys conducted in 2009–2010 and 2016–2017.

Subsequently, in the analysis of the CNHS spanning 2016–2017, the prevalence of CP among the same age cohort was 40% [95% CI: 19%–65%] for participants with cognitive impairment and 39% [95% CI: 30%–49%] for those with normal cognition (Figure 3B, left panel; Table 3). Consistent with the 2009–2010 survey, a slightly higher prevalence of CP was found in female participants with cognitive impairment (52% [95% CI: 23%–79%]), as compared to males with the same cognitive state 18% [95% CI: 6%–47%]) (Figure 3B, right panel; Table 3).

Furthermore, the 2009–2010 survey showed comparable prevalence of single-site and multi-site CP among individuals with normal cognition and those with cognitive impairment (Figure 3C; Supplementary Table 4). Similarly, the 2016–2017 survey indicates consistent prevalence for both cognitive states (Figure 3D; Supplementary Table 4). No significant differences were observed between female and male and subjects reporting single-site or multi-site CP across cognitive states.

Finally, analysis between the MMSE score and the number of painful sites, revealed that individuals with cognitive impairment tended to experience pain in a greater number of anatomical sites (Figure 3E, left and right panels). Specifically, in the 2016–2017 CNHS data, individuals with cognitive impairment were 1.19 [1.01–1.40] times more likely to report pain in various anatomical sites than those with normal cognition (Figure 3F, lower panel). No significant results were found in the 2009–2010 survey (Figure 3F, upper panel).

4 Discussion

In a representative sample, we investigated the prevalence of CP in the Chilean population using data from the 2009–2010 and 2016–2017 CNHS. Our analyses revealed a CP prevalence of 46.5% (female: 64.9%) in the 2009–2010 survey and 29.6% (female: 69.6%) in the 2016–2017 survey, in participants 60–80 years.

Age-specific analysis revealed a higher prevalence of CP with increasing age, peaking at 59% and 42% in the 65–80-year age group for the 2009–2010 and 2016–2017 survey periods, respectively.

Additionally, our findings confirmed a consistently higher prevalence of CP among females across all age groups in both survey periods. These sex differences were statistically significant among individuals aged 15–64 years (p < 0.05) but not in those aged 65–80 years, where prevalence levels between sexes converged. This pattern suggests that gender disparities in CP are more pronounced during early and mid-adulthood and tend to diminish in older age. This attenuation may be explained by the general increase in CP prevalence with aging across both sexes, which has been widely reported in the literature and may reduce the relative difference between males and females in later life (; ; ). Structural barriers—such as limited access to specialized pain management services, unequal healthcare utilization, and entrenched gender roles—may influence the experience and reporting of pain among women across the lifespan (; ; ). However, cultural norms and gendered expectations regarding health-seeking behaviors likely have a stronger impact in younger and working-age populations, contributing to the observed sex differences in the 15–64 age range (; ). Across both surveys, the most commonly affected anatomical sites remained the lower back and knees, consistent across age groups. These findings mirror global patterns and reflect the dual influence of occupational exposures (more prevalent in younger adults) and age-related musculoskeletal degeneration, such as osteoarthritis, in older individuals (; ).

The logistic regression analysis provided critical insights into the determinants of CP in the Chilean population. Our findings indicated that reduced mobility was the most significant factor associated with CP in both the 2009–2010 and 2016–2017 surveys, underscoring the critical importance of functional status in the experience of pain. This relation aligns with recent research that reported that the decreased range of motion and mobility limitations were strongly associated with increased pain and disability in older adults and those with conditions like knee osteoarthritis ().

Anxiety also emerged as a significant factor, emphasizing the interplay between mental health and CP in Chile. This association is well-documented in other regions, with numerous studies indicating that anxiety and other psychological factors are crucial determinants of CP experiences (; ; ; ; ). The consistent identification of these factors across different survey periods accentuate the necessity for integrated management strategies that address both physical and mental health dimensions. Depression was significantly associated with CP in the 2009–2010 survey but not in the 2016–2017 survey. Previous research has shown that CP and depression often co-occur, with each condition potentially exacerbating the other (; ; ; ; ). The discrepancy between the results that we observed in depression and CP in the 2009–2010 and 2016–2017 survey may suggest potential changes in the mental health landscape or reporting practices over time. Taken together, our results highlight the multifaceted nature of CP in the relation to both physical and mental health in Chile.

Notably, our findings from the 2009–2010 survey indicate that individuals with higher SES and education levels had a lower likelihood of reporting CP. However, this finding was not observed in the 2016–2017 survey. This might reflect evolving socioeconomic conditions in Chile or differences in the population samples. Notably, while aging, lower educational attainment, and female sex have previously been recognized as risk factors associated with CP in LA (; ; ; ; ; ; ), the identification of a relationship between SES and CP in Chile is a novel contribution of this study. Our findings highlight the necessity for addressing, in addition to physiological aspects of pain, the broader socioeconomic determinants that contribute to CP, particularly in regions characterized by pronounced levels of inequality, such as LA (; ; ; ; ; ). Indeed, previous studies have shown that socioeconomic disparities can significantly influence health outcomes, including the prevalence and management of CP (; ). For instance, lower SES is often associated with increased stress, limited access to healthcare, and fewer resources for effective pain management, which can exacerbate the experience of CP (; ).

In line with the aforementioned, differences in CP prevalence in the overall sample from 2009 to 2010 survey (45.5%) and 2016–2017 survey (29.6%) may find a partial explanation in the substantial health and social policy reforms implemented during this period. These included the expansion of the Universal Access with Explicit Guarantees (AUGE) program and the strengthening of primary healthcare services, which improved access to pain and mental health management (). Supporting this interpretation, national statistics from the National Socioeconomic Characterization Survey (CASEN) document a reduction in poverty rates among older adults and an increase in average educational attainment—both of which are known to influence CP outcomes (). These structural improvements may have attenuated the association between CP and socioeconomic disadvantage observed in the earlier survey. Our findings also reaffirmed that CP in Chile is strongly associated with older age, female sex, lower educational attainment, and limited financial resources. To our knowledge, this is the first study to characterize this constellation of factors using robust, population-level data in the Chilean context. While overall CP prevalence was not significantly different between individuals with and without cognitive impairment, we found that those with cognitive impairment were more likely to report multi-site pain in the 2016–2017 cohort. This finding may be due to a smaller number of participants who had both cognitive testing and CP measures available and may also reflect the cross-sectional nature of our study. Indeed, previous longitudinal studies have revealed a bidirectional relationship between CP and cognitive impairment, where initial CP predicts subsequent cognitive impairment which then predicts further CP, adding complexity to understanding the CP-dementia relationship (; ; ). When examining cognition in more depth, we found that worse cognitive performance was associated with greater multi-site pain, however, this was restricted to the 2016–2017 CNHS where data was available.

Our study has several strengths that contribute to the understanding of CP within the Chilean population. Firstly, the use of large, nationally representative samples from two distinct time points, along with a sampling method that ensures representativeness and generalizability to the Chilean population, supports the robustness and applicability of the findings. With 4,683 subjects in the 2009–2010 CNHS and 4,887 in the 2016–2017 CNHS, representing more than 12 million Chileans each, our sample sizes are significantly larger than those of previous studies (; ), allowing for more accurate and reliable estimates of CP prevalence. Secondly, the richness of the survey data allowed us to investigate a comprehensive set of associated factors, ranging from sociodemographic variables, nutrition status, and mental and cognitive health. Further, the addition of classic and advanced statistical techniques, such as machine learning algorithms like XGBoost, enhances the precision and predictive power of our findings.

This study has several limitations that should be acknowledged. First, its cross-sectional design precludes any inference of causal relationships between CP and the associated factors identified. Longitudinal studies will be necessary to establish temporal dynamics. Second, the potential underdiagnosis of cognitive impairment and dementia in the older adult population (; ) may have influenced the observed associations between cognitive functioning and CP. Diagnostic limitations in survey-based cognitive assessments and potential misclassification should be considered when interpreting these results. Third, the reliance on self-reported measures—including the presence of CP and comorbid conditions—and the lack of detailed information on medication use (e.g., analgesics or opioids) may introduce reporting and recall biases. Although the CNHS 2009–2010 and 2016–2017 cycles are the most recently available national datasets with relevant CP indicators, the current epidemiological landscape may have evolved, particularly in the wake of recent social, economic, and global events. Nevertheless, these datasets offer a valuable and representative baseline for understanding CP and its determinants in Chile. Future research should address these limitations through the use of longitudinal designs that allow for tracking changes in CP and its contributing factors over time. Improving the accuracy of cognitive assessments and expanding data collection to include additional contextual, behavioral, and clinical variables—such as healthcare access, pain attitudes, and treatment use—could further illuminate the complex nature of CP. Such evidence would be critical for developing tailored, equity-focused public health interventions to reduce the burden of CP, especially among socioeconomically vulnerable populations.

This study represents the first comprehensive characterization of CP prevalence and its associated factors using nationally representative data in Chile. Beyond identifying demographic, socioeconomic, and health-related correlates, our findings highlight the importance of incorporating the broader psychosocial and functional context in the assessment and management of CP. In clinical settings, this involves not only considering pain intensity or anatomical distribution, but also recognizing co-occurring conditions such as mobility limitations, mood disturbances, and cognitive changes that may shape the lived experience of pain. Similarly, in patients presenting with these comorbidities, early assessment of pain may contribute to a more complete clinical picture. These insights point to the need for future research that examines the dynamic interplay between CP and its associated factors over time and informs the development of care strategies that are responsive to the contextual and structural determinants shaping the burden of CP in aging populations.

Statements

Data availability statement

The datasets presented in this study can be found in online repositories. The names of the repository/repositories and accession number(s) can be found below: https://github.com/carolina-gonzalez-silva/Chronic-Pain-in-the-Chilean-population-prevalence-and-associated-factors.

Ethics statement

The survey protocol review was entrusted, with the agreement of the Public Health Subsecretariat of the Ministry of Health, to the Research Ethics Committee of the School of Medicine of the Faculty of Medicine at the Pontificia Universidad Católica (Pontifical Catholic University of Chile—(No. 16–019). The studies were conducted in accordance with the local legislation and institutional requirements. Written informed consent for participation in this study was provided by the participants’ legal guardians/next of kin.

Author contributions

HH: Conceptualization, Methodology, Formal analysis, Writing – original draft, Writing – review and editing. CO-R: Conceptualization, Writing – original draft, Writing – review and editing. AI: Investigation, Validation, Visualization, Writing – review and editing. LOy: Investigation, Supervision, Validation, Visualization, Writing – review and editing. LOl: Investigation, Validation, Visualization, Writing – review and editing, Supervision. NM-D: Writing – review and editing. AC: Supervision, Validation, Visualization, Writing – review and editing. JH: Validation, Visualization, Writing – review and editing, Supervision. TR: Supervision, Validation, Visualization, Writing – review and editing. HS-G: Supervision, Validation, Visualization, Writing – review and editing. NC: Supervision, Validation, Visualization, Writing – review and editing. RM: Supervision, Validation, Visualization, Writing – review and editing. MB: Supervision, Validation, Visualization, Writing – review and editing. JA-F: Supervision, Validation, Visualization, Writing – review and editing. DM: Supervision, Validation, Visualization, Writing – review and editing. RC: Supervision, Validation, Visualization, Writing – review and editing. FP-R: Supervision, Validation, Visualization, Writing – review and editing. AS: Supervision, Validation, Visualization, Writing – review and editing. CD-A: Conceptualization, Supervision, Writing – original draft. CG-S: Conceptualization, Supervision, Writing – original draft, Writing – review and editing.

Funding

The author(s) declare that financial support was received for the research and/or publication of this article. CDA is supported by ANID/FONDECYT Regular 1210622, ANID/PIA/ANILLOS ACT210096, Alzheimer’s Association (AARGD-24-1310017), ANID/FOVI240065, and CARE-2025-0883490149. AI is supported by grants from ANID/FONDECYT Regular (1210195, 1210176, and 1220995); ANID/FONDAP/15150012; Takeda CW2680521; and the MULTI-PARTNER CONSORTIUM TO EXPAND DEMENTIA RESEARCH IN LATIN AMERICA [ReDLat, supported by National Institutes of Health, National Institutes of Aging (R01 AG057234), Alzheimer’s Association (SG-20-725707), Rainwater Charitable Foundation - Tau Consortium, and Global Brain Health Institute]. CDA, AI, AS, and RdlC are supported by grant ANID/PIA/ANILLO ACT210096. COR is supported by AARGD-24-1310017, Bright Focus Standard Award Program iGn Alzheimer’s Disease Research A2025027S, ANID/NAM23I0096, ANID/FONDECYT 1231000, ANID/FOVI240065, Alzheimer’s Association Grant SG-20-725707, The Bluefield Project to Cure Frontotemporal Dementia A140624, and the National Institutes of Health (NIH) (R01AG075775, R01AG083799, and R01AG082056). The contents of this publication are solely the responsibility of the authors and do not represent the official views of these institutions.

Acknowledgments

We would like to express our gratitude to the participants and professionals who contributed to the 2009–2010 and 2016–2017 Chilean National Health Surveys. Their participation and efforts were essential for the development of this study.

Conflict of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.

Generative AI statement

The author(s) declare that no Generative AI was used in the creation of this manuscript.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Supplementary material

The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fragi.2025.1548667/full#supplementary-material

References

  • 1

    Adkins‐JacksonP. B.GeorgeK. M.BesserL. M.HyunJ.LamarM.Hill‐JarrettT. G.et al (2023). The structural and social determinants of Alzheimer’s disease related dementias. Alzheimer’s and Dementia19 (7), 31713185. 10.1002/alz.13027

  • 2

    Aguilar-LatorreA.Asensio-MartínezÁ.Oliván-BlázquezB.Álvarez-BuenoC.Cavero-RedondoI.LionisC.et al (2023). Association between sense of coherence and depression in patients with chronic pain: a systematic review and meta-analysis. PLos One18 (1), e0279959. 10.1371/journal.pone.0279959

  • 3

    AndradeC. (2015). Understanding relative risk, odds ratio, and related terms: as simple as it can get. J. Clin. Psychiatry76 (07), e857e861. 10.4088/JCP.15f10150

  • 4

    ArandaM. P.MarquezD. X.Gallagher-ThompsonD.PérezA.RojasJ. C.HillC. V.et al (2023). A call to address structural barriers to Hispanic/Latino representation in clinical trials on Alzheimer’s disease and related dementias: a micro-meso-macro perspective. Alzheimer’s and Dementia Transl. Res. and Clin. Interventions9 (2), e12389. 10.1002/trc2.12389

  • 5

    Arango-DávilaC. A.Rincón-HoyosH. G. (2018). Depressive disorder, anxiety disorder and chronic pain: multiple manifestations of a common clinical and pathophysiological core. Rev. Colomb. Psiquiatr. (Engl. Ed.)47 (1), 4655. 10.1016/j.rcp.2016.10.007

  • 6

    AsmundsonG. J.KatzJ. (2009). Understanding the co‐occurrence of anxiety disorders and chronic pain: state‐of‐the‐art. Depress. anxiety26 (10), 888901. 10.1002/da.20600

  • 7

    BaezS.AlladiS.IbanezA. (2023). Global South research is critical for understanding brain health, ageing and dementia. Clin. and Transl. Med13 (11), e1486. 10.1002/ctm2.1486

  • 8

    Bartoskova PolcrovaA.DaleckaA.SzaboD.Gonzalez RivasJ. P.BobakM.PikhartH. (2023). Social and environmental stressors and cardiometabolic risk. Eur. J. Public Health33 (Suppl. ment_2), ckad1601258. 10.1093/eurpub/ckad160.1258

  • 9

    BefusD. R.IrbyM. B.CoeytauxR. R.PenzienD. B. (2018). A critical exploration of migraine as a health disparity: the imperative of an equity-oriented, intersectional approach. Curr. pain headache Rep.22, 798. 10.1007/s11916-018-0731-3

  • 10

    BilbenyN.MirandaJ. P.EberhardM. E.AhumadaM.MéndezL.OrellanaM. E.et al (2018). Survey of chronic pain in Chile – prevalence and treatment, impact on mood, daily activities and quality of life. Scand. J. Pain18 (3), 449456. 10.1515/sjpain-2018-0076

  • 11

    BonathanC.HearnL.WilliamsACDC (2013). Socioeconomic status and the course and consequences of chronic pain. Pain Manage3 (3), 159162. 10.2217/pmt.13.18

  • 12

    CaoS.FisherD. W.YuT.DongH. (2019). The link between chronic pain and Alzheimer’s disease. J. Neuroinflammation16 (1), 204. 10.1186/s12974-019-1608-z

  • 13

    Castañeda MoralesV. M.Jiménez GarduñoA. M.EscárcegaM. V.Sánchez VelázquezL. D.Becerra LaparraI. (2015). Association between chronic pain and frailty in mexican elders. J. Frailty Aging, 13. 10.14283/jfa.2015.71

  • 14

    ChenJ.WangX.XuZ. (2023). The relationship between chronic pain and cognitive impairment in the elderly: a review of current evidence. JPR16, 23092319. 10.2147/JPR.S416253

  • 15

    ChenT.GuestrinC. (2016). “XGBoost: a scalable tree boosting system,” in En: Proceedings of the 22nd ACM SIGKDD International Conference on Knowledge Discovery and Data Mining (California USA: ACM), 785794. 10.1145/2939672.2939785

  • 16

    ClarkC. M.DeCarliC.MungasD.ChuiH. I.HigdonR.NuñezJ.et al (2005). Earlier onset of alzheimer disease symptoms in latino individuals compared with anglo individuals. Archives Neurology62 (5), 774778. 10.1001/archneur.62.5.774

  • 17

    CohenS. P.VaseL.HootenW. M. (2021). Chronic pain: an update on burden, best practices, and new advances. Lancet397 (10289), 20822097. 10.1016/S0140-6736(21)00393-7

  • 18

    CostiganM.ScholzJ.WoolfC. J. (2009). Neuropathic pain: a maladaptive response of the nervous system to damage. Annu. Rev. Neurosci.32 (1), 132. 10.1146/annurev.neuro.051508.135531

  • 19

    DeckersK.CadarD.van BoxtelM. P.VerheyF. R.SteptoeA.KöhlerS. (2019). Modifiable risk factors explain socioeconomic inequalities in dementia risk: evidence from a population-based prospective cohort study. J. Alzheimer’s Dis.71 (2), 549557. 10.3233/JAD-190541

  • 20

    DeguenS.AmuzuM.SimoncicV.Kihal-TalantikiteW. (2022). Exposome and social vulnerability: an overview of the literature review. Int. J. Environ. Res. Public Health19 (6), 3534. 10.3390/ijerph19063534

  • 21

    DellarozaM. S. G.PimentaCADMDuarteY. A.LebrãoM. L. (2013). Dor crônica em idosos residentes em São Paulo, Brasil: prevalência, características e associação com capacidade funcional e mobilidade (Estudo SABE). Cad. Saúde Pública29 (2), 325334. 10.1590/s0102-311x2013000200019

  • 22

    De Moraes VieiraÉ. B.GarciaJ. B. S.Da SilvaA. A. M.Mualem AraújoR. L. T.JansenR. C. S. (2012). Prevalence, characteristics, and factors associated with chronic pain with and without neuropathic characteristics in São Luís, Brazil. J. Pain Symptom Manag.44 (2), 239251. 10.1016/j.jpainsymman.2011.08.014

  • 23

    DuránJ.Tejos-BravoM.CidV.FerreccioC.CalvoM. (2023). Chronic pain in Chile: first prevalence report of noncancer chronic pain, fibromyalgia, and neuropathic pain and its associated factors. Pain164 (8), 18521859. 10.1097/j.pain.0000000000002886

  • 24

    DuránJ.ZitkoP.BarriosP.MargozziniP. (2021). Chronic musculoskeletal pain and chronic widespread pain in Chile: prevalence study performed as part of the national health survey. J. Clin. Rheumatol.27 (6S), S294S300. 10.1097/RHU.0000000000001642

  • 25

    EdwardsR. R.CampbellC.SchreiberK. L.MeintsS.LazaridouA.MartelM. O.et al (2022). Multimodal prediction of pain and functional outcomes 6 months following total knee replacement: a prospective cohort study. BMC Musculoskelet. Disord.23 (1), 302. 10.1186/s12891-022-05239-3

  • 26

    FittipaldiS.MigeotJ.IbanezA. (2024). Socioeconomic disparities harm social cognition. Trends Cognitive Sci.28, 386387. 10.1016/j.tics.2023.12.005

  • 27

    FolsteinM. F.FolsteinS. E.McHughP. R. (1975). “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J. Psychiatric Res.12 (3), 189198. 10.1016/0022-3956(75)90026-6

  • 28

    GündoğduS. (2023). Efficient prediction of early-stage diabetes using XGBoost classifier with random forest feature selection technique. Multimed. Tools Appl.82 (22), 3416334181. 10.1007/s11042-023-15165-8

  • 29

    IbanezA.MelloniL.ŚwiebodaP.HynesW.IkizB.AyadiR.et al (2024). Neuroecological links of the exposome and one health. Neuron112 (12), 19051910. 10.1016/j.neuron.2024.04.016

  • 30

    IcazaM. G.AlbalaC. (1999). “Minimental State Examination: Análisis estadístico del estudio de demencia en Chile para validar una versión abreviada,” in Investigacones en Salud Pública: Documentos Técnicos, publicado por la Organización Panamericana de la Salud. Washington, DC.

  • 31

    InnesK. E.SambamoorthiU. (2020). The potential contribution of chronic pain and common chronic pain conditions to subsequent cognitive decline, new onset cognitive impairment, and incident dementia: a systematic review and conceptual model for future research. JAD78 (3), 11771195. 10.3233/JAD-200960

  • 32

    JenniferS.BradyB. R.IbrahimM. M.HerderK. E.WallaceJ. S.PadillaA. R.et al (2024). Co-occurrence of chronic pain and anxiety/depression symptoms in US adults: prevalence, functional impacts, and opportunities. Pain165 (3), 666673. 10.1097/j.pain.0000000000003056

  • 33

    KalariaR.MaestreG.MahinradS.AcostaD. M.AkinyemiR. O.AlladiS.et al (2024). The 2022 symposium on dementia and brain aging in low‐ and middle‐income countries: highlights on research, diagnosis, care, and impact. Alzheimer’s and Dementia, 13836. 10.1002/alz.13836

  • 34

    KawaiK.KawaiA. T.WollanP.YawnB. P. (2017). Adverse impacts of chronic pain on health-related quality of life, work productivity, depression and anxiety in a community-based study. Fam. Pract.34 (6), 656661. 10.1093/fampra/cmx034

  • 35

    LasalviaP.Gil-RojasY.RosselliD. (2022). Burden of disease of chronic pain in Colombia. Expert Rev. Pharmacoeconomics and Outcomes Res.22 (8), 12611267. 10.1080/14737167.2022.2125872

  • 36

    LeãoF. K. A. S.BastosTRPDAndradeD. C. D.SilvaA. M.AppolinarioJ. C.TeixeiraM. J.et al (2016). Prevalence of chronic pain in a metropolitan area of a developing country: a population-based study. Arq. Neuro-Psiquiatr74 (12), 990998. 10.1590/0004-282x20160156

  • 37

    LemeM. de O. P.YuanS. L. K.MagalhãesM. O.de MenesesS. F.MarquesA. P. (2019). Pain and quality of life in knee osteoarthritis, chronic low back pain and fibromyalgia: a comparative cross-sectional study. Reumatismo71 (2), 6874. 10.4081/reumatismo.2019.1104

  • 38

    LermanS. F.RudichZ.BrillS.ShalevH.ShaharG. (2015). Longitudinal associations between depression, anxiety, pain, and pain-related disability in chronic pain patients. Psychosom. Med.77 (3), 333341. 10.1097/PSY.0000000000000158

  • 39

    LeyvaE. O.BockosI. F.Vela BarbaC. L.AldazabalD. A.VitorinoC. E.García-MostajoJ. A.et al (2023). Pain prevalence and chronicity in a developing country in Latin America: a population-based survey in Lima, Peru. Pain Manag.13 (1), 4559. 10.2217/pmt-2022-0061

  • 40

    Maia Costa CabralD.Sawaya Botelho BracherE.Dylese Prescatan DepintorJ.Eluf-NetoJ. (2014). Chronic pain prevalence and associated factors in a segment of the population of São Paulo city. J. Pain15 (11), 10811091. 10.1016/j.jpain.2014.07.001

  • 41

    MartineauD. B.FornasiniM.SuárezD.PazM.ValarezoC.LoorE.et al (2023). Epidemiology of non-oncological high-impact chronic pain in Ecuadorian adults in 2022. Pain Manag.13 (12), 689699. 10.2217/pmt-2023-0055

  • 42

    MartínezN. T.Gómez-RestrepoC.RamírezS.RodríguezM. N. (2016). Prevalencia de trastornos del afecto y de ansiedad en personas con condiciones crónicas. Resultado de la Encuesta Nacional de Salud Mental Colombia 2015. Rev. Colomb. Psiquiatr.45, 141146. 10.1016/j.rcp.2016.06.001

  • 43

    MeghaniS. H.PolomanoR. C.TaitR. C.VallerandA. H.AndersonK. O.GallagherR. M. (2012). Advancing a national agenda to eliminate disparities in pain care: directions for health policy, education, practice, and research. Pain enero13 (1), 528. 10.1111/j.1526-4637.2011.01289.x

  • 44

    MigeotJ.PanessoC.Duran-AniotzC.Ávila-RincónC.OchoaC.HuepeD.et al (2024). Allostasis, health, and development in Latin America. Neurosci. and Biobehav. Rev.162, 105697. 10.1016/j.neubiorev.2024.105697

  • 45

    MilaniS. A.BellT. R.CroweM.PopeC. N.DownerB. (2023). Increasing pain interference is associated with cognitive decline over four years among older Puerto Rican adults. Journals Gerontology Ser. A78 (6), 10051012. 10.1093/gerona/glac141

  • 46

    MilaniS. A.SanchezC.KuoY.DownerB.Al SnihS.MarkidesK. S.et al (2024). Pain and incident cognitive impairment in very old Mexican American adults. J Am. Geriatrics Soc.72 (1), 226235. 10.1111/jgs.18618

  • 47

    Ministry of Health (MINSAL) (2010). National health survey 2009–2010: first report of results. Available online at: https://epi.minsal.cl/wp-content/uploads/2016/05/presentacioÌ_nENS2010final-20-de-enero.pdf.

  • 48

    Ministry of Social Development and Family (2018). “Older adults results,” in CASEN survey 2017 (Chile: Government of Chile), 53. Available online at: https://observatorio.ministeriodesarrollosocial.gob.cl.

  • 49

    Ministry of Health (MINSAL) (2017). National health survey 2016–2017: main results. Available online at: https://redsalud.ssmso.cl/wp-content/uploads/2018/02/ENS-2016-17_PRIMEROS-RESULTADOS-ilovepdf-compressed.pdf.

  • 50

    MoreteM. C.SolanoJ.BoffM.Jacob-FilhoW.AshmawiH. (2018). Resilience, depression, and quality of life in elderly individuals with chronic pain followed up in an outpatient clinic in the city of São Paulo, Brazil. JPR11, 25612566. 10.2147/JPR.S166625

  • 51

    MoriartyO.McGuireB. E.FinnD. P. (2011). The effect of pain on cognitive function: a review of clinical and preclinical research. Prog. Neurobiol.93 (3), 385404. 10.1016/j.pneurobio.2011.01.002

  • 52

    MüllerA. C.GuidoS. (2016). Introduction to machine learning with Python: a guide for data scientists. Sebastopol, CA: O’Reilly Media, Inc.

  • 53

    NahinR. L.DeKoskyS. T. (2020). Comorbid pain and cognitive impairment in a nationally representative adult population: prevalence and associations with health status, health care utilization, and satisfaction with care. Clin. J. Pain36 (10), 725739. 10.1097/AJP.0000000000000863

  • 54

    NuttallF. Q. (2015). Body Mass Index: obesity, BMI, and health A critical review. Nutr. Today50 (3), 117128. 10.1097/NT.0000000000000092

  • 55

    OliveiraAMBDTeixeiraDSDCMenezesF. D. S.MarquesA. P.DuarteYADOCasarottoR. A. (2023). Socioeconomic and sex inequalities in chronic pain: a population-based cross-sectional study. PLoS ONE18 (5), e0285975. 10.1371/journal.pone.0285975

  • 56

    PazM. G. D.SouzaLAFDTatagibaBDSFSerraJ. R. D.MouraL. A. D.BarbosaM. A.et al (2021). Factors associated with quality of life of older adults with chronic pain. Rev. Bras. Enferm.74 (Suppl. 2), e20200554. 10.1590/0034-7167-2020-0554

  • 57

    PereiraF. G.FrançaM. H.PaivaMCADAndradeL. H.VianaM. C. (2017). Prevalence and clinical profile of chronic pain and its association with mental disorders. Rev. saúde pública51, 96. 10.11606/S1518-8787.2017051007025

  • 58

    PereiraL. V.VasconcelosP. P. D.SouzaL. A. F.PereiraG. D. A.NakataniA. Y. K.BachionM. M. (2014). Prevalence and intensity of chronic pain and self-perceived health among elderly people: a population-based study. Rev. Latino-Am Enferm.22 (4), 662669. 10.1590/0104-1169.3591.2465

  • 59

    PhelpsC. E.NavratilovaE.PorrecaF. (2021). Cognition in the chronic pain experience: preclinical insights. Trends Cognitive Sci.25 (5), 365376. 10.1016/j.tics.2021.01.001

  • 60

    PradoP.MedelV.Gonzalez-GomezR.Sainz-BallesterosA.VidalV.Santamaría-GarcíaH.et al (2023). The BrainLat project, a multimodal neuroimaging dataset of neurodegeneration from underrepresented backgrounds. Sci. Data10 (1), 889. 10.1038/s41597-023-02806-8

  • 61

    Python Software Foundation (2024). Python programming language. Available online at: https://www.python.org/.

  • 62

    RajaS. N.CarrD. B.CohenM.FinnerupN. B.FlorH.GibsonS.et al (2020). The revised International Association for the Study of Pain definition of pain: concepts, challenges, and compromises. Pain161 (9), 19761982. 10.1097/j.pain.0000000000001939

  • 63

    SagiO.RokachL. (2018). Ensemble learning: a survey. WIREs Data Min and Knowl8 (4), e1249. 10.1002/widm.1249

  • 64

    Santamaria-GarciaH.Sainz-BallesterosA.HernandezH.MoguilnerS.MaitoM.Ochoa-RosalesC.et al (2023). Factors associated with healthy aging in Latin American populations. Nat septiembre29 (9), 22482258. 10.1038/s41591-023-02495-1

  • 65

    SchmiesingA.LiangY.TurnerB. J. (2022). Association of nonpharmacologic chronic pain management with function in a low‐income population: evidence from a survey of a sample of Latinos from five states. PM&R14 (11), 13431350. 10.1002/pmrj.12701

  • 66

    SerraJ. R. D.SouzaL. A. F.PazM. G. D.TatagibaBDSFPereiraL. V. (2021). Sex differences in coping strategies based on chronic pain intensity among older adults. J. Gerontol. Nurs.47 (10), 3036. 10.3928/00989134-20210908-05

  • 67

    ShahriariB.SwerskyK.WangZ.AdamsR. P.De FreitasN. (2016). Taking the human out of the loop: a review of bayesian optimization. Proc. IEEE104 (1), 148175. 10.1109/jproc.2015.2494218

  • 68

    SilvestreB. A.MiottoL. P.Gramani-SayK.BarbosaM. H.HortenseP. (2023). Chronic pain and associated factors in remote work during the COVID-19 pandemic in Brazil. Rev. Bras. Enferm.76 (Suppl. 1), e20230012. 10.1590/0034-7167-2023-0012

  • 69

    SouzaJ. B. D.GrossmannE.PerissinottiD. M. N.Oliveira JuniorJ. O. D.FonsecaPRBDPossoI. D. P. (2017). Prevalence of chronic pain, treatments, perception, and interference on life activities: Brazilian population-based survey. Pain Res. Manag.2017, 19. 10.1155/2017/4643830

  • 70

    Superintendencia de Salud (2025). Explicit health Guarantees (GES). Chile: Government of Chile. Available online at: https://www.superdesalud.gob.cl (Accessed June 4, 2025).

  • 71

    SzumilasM. (2010). Explaining odds ratios. J. Can. Acad. Child. Adolesc. Psychiatry19 (3), 227229.

  • 72

    TakahashiA.KitamuraK.WatanabeY.KobayashiR.SaitoT.TakachiR.et al (2018). Epidemiological profiles of chronic low back and knee pain in middle-aged and elderly Japanese from the Murakami cohort. J. pain Res.11, 31613169. 10.2147/JPR.S184746

  • 73

    TreedeR. D.RiefW.BarkeA.AzizQ.BennettM. I.BenolielR.et al (2019). Chronic pain as a symptom or a disease: the IASP classification of chronic pain for the international classification of diseases (ICD-11). Pain160 (1), 1927. 10.1097/j.pain.0000000000001384

  • 74

    VélezJ. C.KovasalaM.ColladoM. D.FriedmanL. E.Juvinao-QuinteroD. L.ArayaL.et al (2022). Pain, mood, and suicidal behavior among injured working adults in Chile. BMC Psychiatry22 (1), 766. 10.1186/s12888-022-04391-3

  • 75

    WallaceB.VarcoeC.HolmesC.Moosa-MithaM.MoorG.HudspithM.et al (2021). Towards health equity for people experiencing chronic pain and social marginalization. Int. J. Equity Health20 (1), 53. 10.1186/s12939-021-01394-6

  • 76

    WhitlockE. L.Diaz-RamirezL. G.GlymourM. M.BoscardinW. J.CovinskyK. E.SmithA. K. (2017). Association between persistent pain and memory decline and dementia in a longitudinal cohort of elders. JAMA Intern Med.177 (8), 11461153. 10.1001/jamainternmed.2017.1622

  • 77

    WilliamsD. R.MohammedS. A. (2009). Discrimination and racial disparities in health: evidence and needed research. J. Behav. Med.32 (1), 2047. 10.1007/s10865-008-9185-0

  • 78

    YongR. J.MullinsP. M.BhattacharyyaN. (2022). Prevalence of chronic pain among adults in the United States. Pain163 (2), e328e332. 10.1097/j.pain.0000000000002291

  • 79

    ZimmerZ.FraserK.Grol-ProkopczykH.ZajacovaA. (2022). A global study of pain prevalence across 52 countries: examining the role of country-level contextual factors. Pain163 (9), 17401750. 10.1097/j.pain.0000000000002557

  • 80

    ZitkoP.BilbenyN.BalmacedaC.AbbottT.CarcamoC.EspinozaM. (2021). Prevalence, burden of disease, and lost in health state utilities attributable to chronic musculoskeletal disorders and pain in Chile. BMC Public Health21 (1), 937. 10.1186/s12889-021-10953-z

Summary

Keywords

Chile, chronic pain associated factors, cognitive impairment, elderly population, prevalence

Citation

Hernández H, Ochoa-Rosales C, Ibáñez A, Oyanadel L, Olavarria L, Marín-Díaz N, Caviedes A, Hazelton JL, Ramos T, Santamaria-García H, Custodio N, Montesinos R, Bruno MA, Avila-Funes JA, Matallana D, Cruz R, Petermann-Rocha F, Slachevsky A, Duran-Aniotz C and Gonzalez-Silva C (2025) Chronic pain in the Chilean population: risk factors prevalence and cognitive associations. Front. Aging 6:1548667. doi: 10.3389/fragi.2025.1548667

Received

20 December 2024

Accepted

24 June 2025

Published

22 July 2025

Volume

6 - 2025

Edited by

Víctor Manuel Mendoza-Núñez, National Autonomous University of Mexico, Mexico

Reviewed by

Isabel Arrieta-Cruz, Instituto Nacional de Geriatría, Mexico

Martha Sanchez-Rodriguez, National Autonomous University of Mexico, Mexico

Roger Gutiérrez-Juárez, National Autonomous University of Mexico, Mexico

Updates

Copyright

*Correspondence: Claudia Duran-Aniotz, ; Carolina Gonzalez-Silva,

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Figures

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics